PAR 2.27% 22.5¢ paradigm biopharmaceuticals limited..

Chart, page-4089

  1. 588 Posts.
    lightbulb Created with Sketch. 134
    As we have all speculated and PR confirmed in recent preso, MPS deal won't come until after MPS VI results.

    We know the MPS I trial participants are still on the drug and MPS VI will have access for 5 years after trial. So hopefully data is good. It shows BP the ongoing revenue potential.

    You would think once word gets out amongst MPS community, the demand will come.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
22.5¢
Change
0.005(2.27%)
Mkt cap ! $76.95M
Open High Low Value Volume
22.5¢ 22.5¢ 22.5¢ $1.139K 5.061K

Buyers (Bids)

No. Vol. Price($)
4 124240 22.5¢
 

Sellers (Offers)

Price($) Vol. No.
23.5¢ 84962 8
View Market Depth
Last trade - 10.08am 15/08/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.